Clinical Trial

Development and Assessment of the 8-item Chronic Pain Acceptance Questionnaire to Measure Disease Acceptance in Women With Breast Cancer

Study acronym: CPAQ-8-BC
Completed
View on ClinicalTrials.gov →
Summary
This observational study was conducted to develop and test a new self-report questionnaire, the Cancer Pathology Acceptance Questionnaire for Breast Cancer (CPAQ-8-BC), specifically adapted for women diagnosed with Breast Cancer (BC). The primary goal is to evaluate if this new tool is a reliable and valid measure for assessing disease acceptance - defined as the psychological ability to acknowledge and experience cancer-related thoughts, emotions, and physical sensations without excessive avoidance or struggle. The study investigates whether the Cancer Pathology Acceptance Questionnaire for Breast Cancer (CPAQ-8-BC) accurately measures two distinct aspects: the psychological receptivity to the illness (Disease Receptivity) and the commitment to activity engagement despite the disease (Activity Engagement). This short questionnaire is intended for use by healthcare providers and rehabilitation specialists to identify patients who struggle with acceptance, potentially guiding personalized psychological therapies, such as Acceptance and Commitment Therapy (ACT), and improving participation in rehabilitation and overall quality of survivorship.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-03.
Trial Details
NCT Number NCT07328321
Lead Sponsor G. d'Annunzio University
Conditions Breast Cancer
Enrollment 101 participants
Start Date 2025-01-13
Primary Completion 2025-08-19 (estimated)
Study Completion 2025-08-19 (estimated)
Updated on ClinicalTrials.gov 2026-03-13